Celldex Therapeutics, Inc. — Director's Dealing 2013

Jul 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2013-07-01

Reporting Person: KELER TIBOR (Sr. VP & CSO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-01	Incentive Stock Option	$16.36	A	115000	Acquired	2023-07-01	Common Stock (115000)	Direct

Footnotes

F1: 25% vest on July 1, 2014 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.